Quantum Biopharma Ltd. Files Form 6-K
Ticker: QNTM · Form: 6-K · Filed: Apr 21, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Apr 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting-update, corporate-information, foreign-private-issuer
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K on 4/21/25, confirming 20-F annual report filings.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc. as of March 27, 2019) filed a Form 6-K on April 21, 2025, reporting for the month of April 2025. The company, incorporated in A6 with its principal executive offices in Toronto, Canada, is involved in the Pharmaceutical Preparations industry (SIC 2834). This filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing serves as an update for investors regarding Quantum Biopharma Ltd.'s reporting status and corporate information, including its former name and primary business sector.
Risk Assessment
Risk Level: low — This is a routine administrative filing (6-K) that primarily confirms reporting status and provides basic company information, without disclosing new material financial or operational developments.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- 20190327 (date) — Date of name change
- 20250421 (date) — Filing date
- 20250418 (date) — Period of report
- 001-39152 (other) — Commission File Number
- 2834 (other) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2025, indicating the company's reporting status and providing basic corporate information.
What was Quantum Biopharma Ltd. previously known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Where are Quantum Biopharma Ltd.'s principal executive offices located?
The principal executive offices of Quantum Biopharma Ltd. are located at 55 University Ave., Suite 1003, Toronto, Ontario, M5J2H7, Canada.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates by check mark that it files annual reports under cover of Form 20-F.
What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?
The Standard Industrial Classification code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 21, 2025 regarding Quantum Biopharma Ltd. (QNTM).